Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-11-29 Sale | 2023-12-01 12:31 pm | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 148,884 | $0.8664 | $128,993 | 251,522 (Indirect) | View |
2023-11-21 Sale | 2023-11-22 7:45 pm | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 1,943 | $0.9014 | $1,751 | 269,587 (Indirect) | View |
2023-11-16 Sale | 2023-11-20 9:31 pm | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 49,173 | $0.92887 | $45,675 | 269,823 (Indirect) | View |
2021-02-09 Purchase | 2021-02-09 3:25 pm | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 200,000 | $20 | $4,000,000 | 1,496,070 (Indirect) | View |
2021-02-09 Sale | 2021-02-09 3:25 pm | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 164 | $20 | $3,280 | 1,496,070 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-12 Option Award | 2023-06-14 5:13 pm | N/A 2033-06-11 | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-06-10 Option Award | 2022-06-10 6:11 pm | N/A 2032-06-09 | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-03-24 Option Award | 2022-03-28 3:21 pm | N/A 2032-03-23 | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-02-09 Exercise | 2021-02-09 3:25 pm | N/A 2028-07-26 | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 46,608 | $0 | 1,496,070 (Indirect) | View |
2021-02-09 Exercise | 2021-02-09 3:25 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 46,608 | $0.07 | 1,496,070 (Indirect) | View |
2021-02-09 Conversion | 2021-02-09 3:25 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 1,997,991 | $0 | 1,496,070 (Indirect) | View |
Ownership | 2021-02-04 5:55 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner | 0 | $0 | 3,351,396 (Indirect) | View |